Insitu Nasal Gel of Granisetron For Enhancement of Bioavailability Over Oral Delivery: Formulation, Optimization and In-Vivo Evaluation
Abstract
The objective of the present work was formulation, optimization and in-vivo evaluation of in-situ nasal gel of granisetron that shows liquid to gel transformation at nasal temperature (32-34°C) and maximum drug release after 4 hr; shows biovailability enhancement over oral delivery. Formulations were prepared using poloxamer PF 127 as gel forming polymer, carbopol as mucoadhesive agent and fulvic acid as penetration enhancer. A Box Benhken Design was used to prepare the experimental batches and Design Expert software for optimization of the formulation. Ex-vivo evaluations were carried out on sheep nasal mucosa and for in-vivo evaluation, rabbits were used. It was observed that optimized formulation showed gelation temperature near 33°C and drug release of 96% after 4hr. Fulvic acid was evaluated as penetration enhancer in this work and showed significant enhancement of drug diffusion across nasal mucosal membrane. Ex-vivo histological evaluation of nasal mucosa treated with optimized formulation showed no significant destructive effects. In-vivo evaluations showed that the plasma level profile of prepared insitu nasal gel was enhanced significantly over oral delivery. The findings suggested that nasal route nasal transmucosal delivery of granisetron can result in enhancement of its bioavailability over oral route.
Keywords:
granisetron, transmucosal, in-situ nasal gel, poloxamer PF 127, fulvic acid, Box Benhken DesignDOI
https://doi.org/10.25004/IJPSDR.2020.120517References
Moffat AC, Osselton MD, Widdop . Clarke's Analysis of Drugs and Poisons. Edn 3, Pharmaceutical Press, London, 2004, pp. 1086-87.
Dollery C. Therapeutic Drugs. Edn 2, Churchill Livingstone,1999, pp. G86-G90.
Sweetman SC. Martindale: The complete drug reference, Edn 35, Pharmaceutical Press, London, 2007, pp 1526-1602.
Prego C, García M, Torres D, Alonso MJ. Transmucosal macromolecular drug delivery. J Control Release. 2005;101(1-3):151-62.
Behl CR, Pimplaskar HK, Sileno AP, deMeireles J, Romeo VD. Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev.1998; 29, 89–116.
Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, Ping Q. Poly(N-isopropylacrylamide) chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release. 2007;Jul 31;120(3):186-94.
Wiilam AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603-618.
Mirza MA, Talegaonkar S, Ahmed FA, Iqbal Z. A novel and multifaceted excipient for vaginal drug delivery. J Excip Food Chem. 2001;2(4):98-112.
Kirsten Willis. An investigation of the effect of fulvic acid and humic acid on the absorption of selected drugs, vitamins and minerals using the iverted mouse gut model. M.S. Thesis, University of Pretoria. 2015.
Schmolka IR. Preparation and properties of Pluronic F127 gels for the treatment of burns. J Biomedical Mater Res. 1972;6:571-582.
Karnachi A, Khan M. Box-behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures. Int J Pharm. 1996;131(1): 9-17.
Franz RM, Browne JE, Lewis A.R. Pharmaceutical dosage form: Disperse systems Vol. I, Marcel Dekker, NewYork.1998, pp. 427-519.
Angayer Kanchana S, Aruna A, Niraimath V, Jerad Suresh A. Spectrophotometric estimation of granisetron in bulk and tablet formulation. Int J Chem Sci. 2010;8(2):1169-1173.
Miler SC, Donovan MD. Effect of poloxamer 407 gels on the mioticactiviy of pilocarpine nitrates in rabbits, Int J Pharm.1982;142-152.
Garala K, Joshi P, Shah M, Ramkishan A, Patel J. Formulation and evaluation of periodontal in situ gel. Int J Pharm Investig. 2013; 3(1): 29-41.
Pathan IB, Chudiwal V, Farooqui I, Shingare P. Formulation design and evaluation of nasal in situ gel as a novel vehicle for Azelastine hydrochloride. Int J Drug Deliv. 2013;5:284-290.
Pinguet F, Bressolle F, Martel P, Salabert D, Astre C. High-performance liquid chromatographic determination of granisetron in human plasma. Journal Chromatogr B. 1996; 675:99-105.
Jiang Y, Lin M, Fan G, Chen Y, Zhen L, Zhao W, Wu Y, Hu J. Rapid determination of granisetron in human plasma by liquid chromatography coupled to tandem mass spectrometry and its application to bioequivalence study. J Pharm Biomed. 2006;42(4):464-473.
Barichello JM, Morishita M, Takayama K, Nagai T. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. Int J Pharm. 1999; Jul 20;184(2):189-98.
Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev. 2002;54(1):37-51.
Ricci EJ, Lunardi LO, Nanclares DM, Marchetti JM. Sustained release of lidocaine from Poloxamer 407 gels. Int J Pharm. 2005;288(2):235-44.
Published
Abstract Display: 508 
PDF Downloads: 438 
